Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > 1,40 or The Coming-of-Age

<< Previous

Bullboard Posts

Next >>

Post by Vimon66on Nov 28, 2017 9:09pm

191 Views

Post# 27050847

1,40 or The Coming-of-Age

Never thought I'd live to see that moment. But Now that the improbable has materialized, I sincerely don't see what is going to stop us from reaching the Oracle's predication of 1,80. I want to apologyze for all the times I blantly expressed my doubts and mistrust. From now on, I promise to be your most devoted follower. I am subjugated by your power, your dedication and your accomplishment. I would love to learn more about your secret. Oracle, would you teach us your magic? Thank You!!!

<< Previous

Bullboard Posts

Next >>

New CEO leads Sonoro Energy's vision to expand in MENA